| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6K | — |
| Cost of Revenue | $6K | — |
| Gross Profit | -$116 | — |
| R&D Expense | $924K | +540.0% |
| SG&A Expense | $17.6M | +471.0% |
| Operating Income | -$19.4M | -1498.1% |
| Pre-tax Income | -$24.5M | -1770.4% |
| Income Tax | $1K | +0.0% |
| Net Income | -$24.5M | -95.3% |
| EPS (Diluted) | -$16.38 | -762.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $253K | — |
| Current Assets | $1.3M | +2762.4% |
| Total Assets | $1.3M | -80.5% |
| Current Liabilities | $7.6M | -51.4% |
| Total Liabilities | $7.7M | -50.8% |
| Stockholders' Equity | -$6.4M | +59.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | -139.6% |
| Financing Cash Flow | $5.9M | +150.5% |